Arrowhead Pharmaceuticals, Inc. (ARWR) Social Stream



Arrowhead Pharmaceuticals, Inc. (ARWR): $45.88

-1.75 (-3.67%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ARWR to Watchlist
Sign Up

Industry: Biotech


Ranked

of 402

in industry

Arrowhead Pharmaceuticals Inc (ARWR) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Arrowhead Pharmaceuticals Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-15 9 $106 $44 $89.7 $47.11 90.41%
2021-11-24 8 $106 $45 $89.777 $47.11 90.57%
2021-12-15 8 $106 $45 $90.111 $47.11 91.28%
2022-01-12 7 $106 $45 $89.5 $47.11 89.98%
2022-01-28 7 $106 $46 $89.625 $47.11 90.25%
2022-03-23 7 $106 $36 $87.875 $47.11 86.53%

The Trend in the Analyst Price Target


Over the past 128 days, ARWR's average price target has gone down $1.83.

ARWR reports an average of 40.7% for its upside potential over the past 51 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-07-17 12 106 44 89.310 63.43 40.8%
2021-08-01 12 106 44 89.310 69.29 28.89%
2021-08-07 12 106 44 89.000 64.79 37.37%
2021-09-20 10 106 44 87.920 62.40 40.9%
2021-11-23 8 106 45 89.777 70.89 26.64%

ARWR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.29 6 0 1 0 0 7

The Trend in the Broker Recommendations


Over the past 24 months, ARWR's average broker recommendation rating improved by 0.93.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ARWR as an investment opportunity.

  • Arrowhead Pharmaceuticals Inc's variance in analysts' estimates is lower than -635.44% of all US stocks.
  • ARWR has a greater average analyst price target than 754.74% of Pharmaceutical Products stocks.
  • In the context of stocks in the mid market cap category, Arrowhead Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is higher than 699.89% of them.
  • In terms of how Arrowhead Pharmaceuticals Inc fares relative to Pharmaceutical Products stocks, note that its number of analysts covering the stock is greater than 606.26% of that group.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Arrowhead Pharmaceuticals Inc are ARVN, APLS, and ANAB.

Is ARWR a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4614 seconds.